Health Care

Pfizer pumps $600M into venture capital arm

Several drugmakers, including Pfizer, have cut back on neuroscience research after a string of costly trials yielded disappointing results, with some of them betting on startups that are focusing on such areas.

Poll: Seniors ready to Skype doctors, care quality a concern

Every morning, 92-year-old Sidney Kramer wraps a blood pressure cuff around his arm and steps on a scale, and readings of his heart health beam to a team of nurses — and to his daughter's smartphone — miles from his Maryland home.